TerminatedPhase 2

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover)

NCT04483479

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

The Parkinson's and Movement Disorder Institute

Fountain Valley, California, United States

+17 additional locations

Save this trial

The Parkinson's and Movement Disorder InstituteFountain Valley, California, United States
SC3 Research - PasadenaPasadena, California, United States
Rocky Mountain Movement Disorders CenterEnglewood, Colorado, United States
Georgetown Universtiy, Department of NeurologyWashington D.C., District of Columbia, United States
JEM Research InstituteAtlantis, Florida, United States
Parkinson's Disease and Movement Disorders Center of Boca RatonBoca Raton, Florida, United States
Parkinson's Disease Treatment Center of SWFLPort Charlotte, Florida, United States
Intercoastal Medical GroupSarasota, Florida, United States
USF Health Byrd Parkinson's Disease Movement Disorders Center of ExcellenceTampa, Florida, United States
Premiere Research Institute at Palm Beach NeurologyWest Palm Beach, Florida, United States
Dartmouth Hitchcock Medical CenterLebanon, New Hampshire, United States
Albany Medical CollegeAlbany, New York, United States
Icahn School of Medicine at Mount SinaiNew York, New York, United States
Cleveland ClinicCleveland, Ohio, United States
University of Toledo Medical CenterToledo, Ohio, United States
Penn State UniversityHershey, Pennsylvania, United States
Evergreen Health - Booth Gardner Parkinson's Care CenterKirkland, Washington, United States
University Physicians & Surgeons, Inc. dba Marshall HealthHuntington, West Virginia, United States